In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene

被引:60
作者
Doubrovin, Mikhail M. [1 ]
Doubrovina, Ekaterina S. [1 ]
Zanzonico, Pat [1 ]
Sadelain, Michel [1 ]
Larson, Steven M. [1 ]
O'Reilly, Richard J. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1158/0008-5472.CAN-07-1250
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sequential imaging of genetically marked effector cells after adoptive transfer in vivo has greatly enhanced analyses of their biodistribution, growth, and activity both in animal models and in clinical trials of cellular immunotherapy. However, the immunogenicity of cells expressing xenogeneic reporter constructs limits their survival and clinical utility. To address this limitation, we have evaluated a human norepinephrine transporter (hNET) permitting imaging of transduced cells in vivo with a previously approved clinical grade radiolabeled probe, metaiodobenzylguanidine (MIBG). The hNET gene cDNA was cloned from the SK-N-SH cell line and inserted into a bicistronic retroviral vector also encoding green fluorescent protein. Following transfection, human EBV-specific T lymphocytes were fully functional in vitro and also selectively accumulated [I-123]MIBG. In nonobese diabetic/severe combined immunodeficient mice bearing human EBV lymphoma xenografts, as few as 10(4) transduced T cells injected into the tumors could be imaged by single-photon emission computed tomography (SPECT) or positron emission tomography (PET) after i.v. infusion of [I-123]MIBG or [I-124]MIBG, respectively. When hNET(+) EBV-specific T cells were infused i.v., their migration and specific accumulation in EBV+ tumors expressing their restricting HLA allele could be imaged by SPECT or PET over 28 days. Image intensity was closely correlated with the number of T cells accumulated in targeted tumors. The use of two reporter probes (MIBG and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodouracil) permitted independent contemporaneous tracking of two distinct EBV-specific T-cell subpopulations expressing different reporter genes (hNET-CD4(+) T cells and HSV-TK-CD8(+) T cells) in the same animal using three-dimensional nuclear modalities (SPECT and PET). The hNET-based system described may thus have significant potential as a nonimmunogenic reporter for extended repeated quantitative in vivo imaging of transduced cells in man.
引用
收藏
页码:11959 / 11969
页数:11
相关论文
共 36 条
[1]   The incremental value of 18F-FDG PET/CT in paediatric malignancies [J].
Bar-Sever, Zvi ;
Keidar, Zohar ;
Ben-Barak, Ayelet ;
Bar-Shalom, Rachel ;
Postovsky, Sergey ;
Guralnik, Luda ;
Ben Arush, Myriam W. ;
Israel, Ora .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (05) :630-637
[2]   3-(2'-[F-18]FLUOROETHYL)SPIPERONE - INVIVO BIOCHEMICAL AND KINETIC CHARACTERIZATION IN RODENTS, NONHUMAN-PRIMATES, AND HUMANS [J].
BARRIO, JR ;
SATYAMURTHY, N ;
HUANG, SC ;
KEEN, RE ;
NISSENSON, CHK ;
HOFFMAN, JM ;
ACKERMANN, RF ;
BAHN, MM ;
MAZZIOTTA, JC ;
PHELPS, ME .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1989, 9 (06) :830-839
[3]   In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets [J].
Beilhack, A ;
Schulz, S ;
Baker, J ;
Beilhack, GF ;
Wieland, CB ;
Herman, EI ;
Baker, EM ;
Cao, YA ;
Contag, CH ;
Negrin, RS .
BLOOD, 2005, 106 (03) :1113-1122
[4]   Gene therapy for severe combined immunodeficiency: are we there yet? [J].
Cavazzana-Calvo, Marina ;
Fischer, Alain .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (06) :1456-1465
[5]  
Che Jiantu, 2005, Mol Imaging, V4, P128
[6]   Quantitative imaging of the T cell antitumor response by positron-emission tomography [J].
Dubey, P ;
Su, H ;
Adonai, N ;
Du, SY ;
Rosato, A ;
Braun, J ;
Gambhir, SS ;
Witte, ON .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :1232-1237
[7]  
Haberkorn U, 2001, J NUCL MED, V42, P317
[8]   LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [J].
Hacein-Bey-Abina, S ;
Von Kalle, C ;
Schmidt, M ;
McCcormack, MP ;
Wulffraat, N ;
Leboulch, P ;
Lim, A ;
Osborne, CS ;
Pawliuk, R ;
Morillon, E ;
Sorensen, R ;
Forster, A ;
Fraser, P ;
Cohen, JI ;
de Saint Basile, G ;
Alexander, I ;
Wintergerst, U ;
Frebourg, T ;
Aurias, A ;
Stoppa-Lyonnet, D ;
Romana, S ;
Radford-Weiss, I ;
Gross, F ;
Valensi, F ;
Delabesse, E ;
Macintyre, E ;
Sigaux, F ;
Soulier, J ;
Leiva, LE ;
Wissler, M ;
Prinz, C ;
Rabbitts, TH ;
Le Deist, F ;
Fischer, A ;
Cavazzana-Calvo, M .
SCIENCE, 2003, 302 (5644) :415-419
[9]   Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes [J].
Heslop, HE ;
Ng, CYC ;
Li, CF ;
Smith, CA ;
Loftin, SK ;
Krance, RA ;
Brenner, MK ;
Rooney, CM .
NATURE MEDICINE, 1996, 2 (05) :551-555
[10]   Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system [J].
Huang, X ;
Wilber, AC ;
Bao, L ;
Tuong, D ;
Tolar, J ;
Orchard, PJ ;
Levine, BL ;
June, CH ;
McIvor, RS ;
Blazar, BR ;
Zhou, XZ .
BLOOD, 2006, 107 (02) :483-491